Failure to warn

What is a failure to warn claim?

A failure to warn claim asserts that a product was rendered unreasonably dangerous by inadequate instructions or warnings rather than by any flaw in the item itself.

The product may be well designed and correctly manufactured. What made it dangerous was that users were not told what they needed to know to use it safely.

It is often the most accessible of the three product theories, since it does not require proving an alternative design or a production deviation.

It is also the theory most often paired with others, since a product can be both poorly designed and inadequately labeled.

What makes a warning inadequate?

Adequacy is judged by content and by communication, not merely by existence.

• The warning omitted the specific risk that materialized
• It was buried in dense text a user would not reasonably read
• It was not placed where the danger would be encountered
• It understated the severity or likelihood of the harm
• It was not provided in a language the expected user would understand
• Instructions for safe use were absent or incomplete

What must the manufacturer have known?

The duty generally attaches to risks the manufacturer knew or reasonably should have known about given the scientific knowledge available.

Internal testing, complaint records, adverse event reports and prior litigation all establish knowledge, and discovery into these materials is central to the claim.

A continuing duty may also arise. A manufacturer learning of a danger after sale may be obligated to act on that knowledge.

Post sale duties are litigated in their own right, and what a company did after learning of a danger frequently matters as much as what it knew before.

How does this work for prescription drugs?

Differently, because of the learned intermediary doctrine. The manufacturer's warning duty generally runs to the prescribing physician rather than directly to the patient.

New Jersey has recognized an important qualification where manufacturers advertise directly to consumers, which can affect how the doctrine applies.

Causation in warning cases also requires showing the warning would have changed the outcome, meaning the physician or user would have acted differently.

These cases therefore turn heavily on documents rather than on the product itself, which distinguishes them from design and manufacturing claims.

Common questions

What if I did not read the warning?

Defendants raise this, though the analysis focuses on whether an adequate warning would have been read and heeded. Placement and prominence remain relevant.

Does an obvious danger require a warning?

Generally not. There is usually no duty to warn about risks apparent to any ordinary user.

Can a warning cure a design defect?

No. A warning does not excuse a design that could feasibly have been made safer, and both theories can be pleaded together.

Do warnings have to be in other languages?

Where a manufacturer knows its product reaches users who do not read English, the adequacy of an English only warning becomes a genuine question. Pictograms and multilingual labelling are common in industries where this is anticipated, and their absence can support the claim.